These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 9733451

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Lupus erythematosus tumidus: response to antimalarial treatment in 36 patients with emphasis on smoking.
    Kreuter A, Gaifullina R, Tigges C, Kirschke J, Altmeyer P, Gambichler T.
    Arch Dermatol; 2009 Mar; 145(3):244-8. PubMed ID: 19289751
    [Abstract] [Full Text] [Related]

  • 3. Patients with cutaneous lupus erythematosus who smoke are less responsive to antimalarial treatment.
    Jewell ML, McCauliffe DP.
    J Am Acad Dermatol; 2000 Jun; 42(6):983-7. PubMed ID: 10827400
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and tolerability of methotrexate in antimalarial resistant lupus arthritis.
    Rahman P, Humphrey-Murto S, Gladman DD, Urowitz MB.
    J Rheumatol; 1998 Feb; 25(2):243-6. PubMed ID: 9489814
    [Abstract] [Full Text] [Related]

  • 5. The cholesterol lowering effect of antimalarial drugs is enhanced in patients with lupus taking corticosteroid drugs.
    Rahman P, Gladman DD, Urowitz MB, Yuen K, Hallett D, Bruce IN.
    J Rheumatol; 1999 Feb; 26(2):325-30. PubMed ID: 9972966
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Association of smoking with cutaneous manifestations in systemic lupus erythematosus.
    Bourré-Tessier J, Peschken CA, Bernatsky S, Joseph L, Clarke AE, Fortin PR, Hitchon C, Mittoo S, Smith CD, Zummer M, Pope J, Tucker L, Hudson M, Arbillaga H, Esdaile J, Silverman E, Chédeville G, Huber AM, Belisle P, Canadian Network for Improved Outcomes in Systemic Lupus Erythematosus 1000 Canadian Faces of Lupus Investigators, Pineau CA.
    Arthritis Care Res (Hoboken); 2013 Aug; 65(8):1275-80. PubMed ID: 23401335
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The effect of menopause on disease activity in systemic lupus erythematosus.
    Urowitz MB, Ibañez D, Jerome D, Gladman DD.
    J Rheumatol; 2006 Nov; 33(11):2192-8. PubMed ID: 16981295
    [Abstract] [Full Text] [Related]

  • 12. [Treatment of discoid lupus erythematosus with sulfasalazine: 11 cases].
    Delaporte E, Catteau B, Sabbagh N, Gosselin P, Breuillard F, Doutre MS, Broly F, Piette F, Bergoend H.
    Ann Dermatol Venereol; 1997 Nov; 124(2):151-6. PubMed ID: 9740825
    [Abstract] [Full Text] [Related]

  • 13. Impact of smoking in cutaneous lupus erythematosus.
    Piette EW, Foering KP, Chang AY, Okawa J, Ten Have TR, Feng R, Werth VP.
    Arch Dermatol; 2012 Mar; 148(3):317-22. PubMed ID: 22105815
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Correlation of prolactin serum concentrations with clinical activity and remission in patients with systemic lupus erythematosus. Effect of conventional treatment.
    Vera-Lastra O, Mendez C, Jara LJ, Cisneros M, Medina G, Ariza R, Espinoza LR.
    J Rheumatol; 2003 Oct; 30(10):2140-6. PubMed ID: 14528507
    [Abstract] [Full Text] [Related]

  • 16. [Disorders of conduction in lupus erythematosus : frequency and incidence in a group of 112 patients (author's transl)].
    Godeau P, Guillevin L, Fechner J, Bletry O, Herreman G.
    Ann Med Interne (Paris); 1981 Oct; 132(4):234-40. PubMed ID: 7305172
    [Abstract] [Full Text] [Related]

  • 17. The combination of complement deficiency and cigarette smoking as risk factor for cutaneous lupus erythematosus in men; a focus on combined C2/C4 deficiency.
    Boeckler P, Milea M, Meyer A, Uring-Lambert B, Heid E, Hauptmann G, Cribier B, Lipsker D.
    Br J Dermatol; 2005 Feb; 152(2):265-70. PubMed ID: 15727637
    [Abstract] [Full Text] [Related]

  • 18. Cutaneous lupus erythematosus: factors related to cutaneous activity and damage in a cohort of 260 patients from A Coruña, Spain.
    Arévalo-Bermúdez MDP, Paradela S, Balboa-Barreiro V, Fonseca E.
    Lupus; 2020 Aug; 29(9):1021-1030. PubMed ID: 32539659
    [Abstract] [Full Text] [Related]

  • 19. Low blood concentration of hydroxychloroquine in patients with refractory cutaneous lupus erythematosus: a French multicenter prospective study.
    Francès C, Cosnes A, Duhaut P, Zahr N, Soutou B, Ingen-Housz-Oro S, Bessis D, Chevrant-Breton J, Cordel N, Lipsker D, Costedoat-Chalumeau N.
    Arch Dermatol; 2012 Apr; 148(4):479-84. PubMed ID: 22508872
    [Abstract] [Full Text] [Related]

  • 20. Menopause hormonal therapy in women with systemic lupus erythematosus.
    Sánchez-Guerrero J, González-Pérez M, Durand-Carbajal M, Lara-Reyes P, Jiménez-Santana L, Romero-Díaz J, Cravioto MD.
    Arthritis Rheum; 2007 Sep; 56(9):3070-9. PubMed ID: 17763408
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.